Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April-June 2022.

Kislaya, Irina; Melo, Aryse; Barreto, Marta; Henriques, Camila; Aniceto, Carlos; Manita, Carla; Ramalhete, Sara; Santos, João Almeida; Soeiro, Sofia; Rodrigues, Ana Paula

Kislaya, Irina; Melo, Aryse; Barreto, Marta; Henriques, Camila; Aniceto, Carlos; Manita, Carla; Ramalhete, Sara; Santos, João Almeida; Soeiro, Sofia; Rodrigues, Ana Paula.

Emerg Infect Dis ; 29(3): 590-594, 2023 02.

Article en En | MEDLINE | ID: mdl-36732078

ABSTRACT

ABSTRACT

After the rapid spread of SARS-CoV-2 BA.5 Omicron lineage in Portugal, we developed a seroepidemiologic survey based on a sample of 3,825 residents. Results indicated that from April 27 through June 8, 2022, the estimated seroprevalence of SARS-CoV-2 nucleocapsid or spike IgG was 95.8%, which indicates a high level of protection.

Asunto(s)

COVID-19; Humanos; Portugal; SARS-CoV-2; Estudios Seroepidemiológicos; Anticuerpos Antivirales

Palabras clave

2019 novel coronavirus disease; BA.5; COVID-19; IgG; Omicron; Portugal; SARS-CoV-2; coronavirus disease; respiratory infections; seroepidemiological survey; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Emerg Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google